AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35213 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 31470877 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative game mode
Number of subjects: 40
Study 31470877 — intervention group
Group type: COMPARATOR
Intervention: Competitive game mode
Number of subjects: 40
Study 31470877 — intervention group
Group type: COMPARATOR
Intervention: Co-active game mode
Number of subjects: 40
Study 27635023 — intervention group
Group type: EXPERIMENTAL
Intervention: 90Y‐DOTATOC
Number of subjects: 1535
Study 27635023 — intervention group
Group type: EXPERIMENTAL
Intervention: 177Lu‐DOTATOC
Number of subjects: 1535
Study 27635023 — intervention group
Group type: COMPARATOR
Intervention: Radiopeptide therapy (90Y‐DOTATOC or 177Lu‐DOTATOC)
Number of subjects: 1535
Study 26473561 — intervention group
Group type: EXPERIMENTAL
Intervention: Resilience training combined with cognitive behavioral and solution-focused counseling
Number of subjects: 82
Study 26473561 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 82
Study 24220602 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated software system for identifying patients eligible for OAC therapy and increasing uptake, used in 23 intervention practices for 6 months.
Number of subjects: 0
Study 24220602 — intervention group
Group type: COMPARATOR
Intervention: Usual care in 23 control practices.
Number of subjects: 0
Study 24220602 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated software system for identifying patients eligible for OAC therapy.
Number of subjects: 0
Study 24220602 — intervention group
Group type: COMPARATOR
Intervention: Usual care in control practices.
Number of subjects: 0
Study 21507688 — intervention group
Group type: EXPERIMENTAL
Intervention: EndoSequence Bioceramic Root‐end Repair (BCRR) (n = 15)
Number of subjects: 40
Study 21507688 — intervention group
Group type: EXPERIMENTAL
Intervention: White mineral trioxide aggregate (WMTA) (n = 15)
Number of subjects: 40
Study 21507688 — intervention group
Group type: COMPARATOR
Intervention: Control group (unfilled specimens, n = 10)
Number of subjects: 40
Study 19742335 — intervention group
Group type: EXPERIMENTAL
Intervention: Resection of pancreatic capsule and anterior layer of transverse mesocolon (Group R)
Number of subjects: 213
Study 19742335 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group N)
Number of subjects: 213
Study 17719390 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mL of autologous platelet-poor plasma (PPP) gel
Number of subjects: 24
Study 17719390 — intervention group
Group type: COMPARATOR
Intervention: 1-gram of bovine microfibrillar collagen (MFC)
Number of subjects: 24
Study 15121561 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg
Number of subjects: 1008
Study 15121561 — intervention group
Group type: COMPARATOR
Intervention: Continuous combined estrogen plus progestin therapy (2 mg of 17 beta‐estradiol plus 1 mg of norethisterone acetate)
Number of subjects: 1008
Study 15121561 — intervention group
Group type: COMPARATOR
Intervention: Continuous combined estrogen plus progestin therapy
Number of subjects: 1008
Study 11346146 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alpha 2b 3 Million Units thrice weekly (group A)
Number of subjects: 63
Study 11346146 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alpha 2b 5 Million Units thrice weekly (group B)
Number of subjects: 63
Study 11346146 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alpha 2b 5 Million Units daily (group C)
Number of subjects: 63
Study 9876054 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxycillin/clavulanate (250 mg/62 mg t.i.d. or 125 mg/31 mg t.i.d. if aged under 6 years) for 7 days
Number of subjects: 0
Study 9876054 — intervention group
Group type: COMPARATOR
Intervention: Cefaclor (250 mg t.i.d. or 125 mg t.i.d. if aged under 6 years) for 7 days
Number of subjects: 0
Study 7976408 — intervention group
Group type: EXPERIMENTAL
Intervention: Exhausting treadmill running (5.27 m/s for ET and 5.59 m/s for ST) for 1 minute
Number of subjects: 11
Study 7976408 — intervention group
Group type: EXPERIMENTAL
Intervention: Recovery after exhausting exercise
Number of subjects: 11
Study 7976408 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-exhausting bouts of exercise at lower speed or shorter duration
Number of subjects: 11
Study 2491982 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental intracervical device (ICD)
Number of subjects: 253
Study 2491982 — intervention group
Group type: COMPARATOR
Intervention: Levonorgestrel‐releasing intrauterine device (LNG‐IUD)
Number of subjects: 253
Study 2491982 — intervention group
Group type: COMPARATOR
Intervention: Copper Nova‐T IUD
Number of subjects: 253
Study 2491982 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjusted probabilities of discontinuation for ICD
Number of subjects: 253
Study 2491982 — intervention group
Group type: COMPARATOR
Intervention: Adjusted probabilities of discontinuation for LNG‐IUD
Number of subjects: 253
Study 2491982 — intervention group
Group type: COMPARATOR
Intervention: Adjusted probabilities of discontinuation for Nova‐T
Number of subjects: 253
Study 5053 — intervention group
Group type: EXPERIMENTAL
Intervention: Buffered cephalothin
Number of subjects: 12
Study 5053 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefamandole
Number of subjects: 12
Study 5053 — intervention group
Group type: EXPERIMENTAL
Intervention: Cephapirin
Number of subjects: 12
Study 31760109 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated psychosocial treatment (Acceptance and Commitment Therapy + Mindfulness Based Relapse Prevention)
Number of subjects: 37
Study 31760109 — intervention group
Group type: COMPARATOR
Intervention: Usual care through a Veteran's Administration co‐occurring disorders medical clinic
Number of subjects: 37
Study 31159277 — intervention group
Group type: COMPARATOR
Intervention: Health Behavioural Intervention
Number of subjects: 0
Study 27908210 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined hormonal contraceptive (COC) containing 0.020 mg of ethynyl estradiol (EE)
Number of subjects: 556
Study 27908210 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined hormonal contraceptive (COC) containing 0.030 mg of ethynyl estradiol (EE)
Number of subjects: 556
Study 27908210 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural COC containing 1.5 mg of estradiol (E2)
Number of subjects: 556
Study 27908210 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal ring releasing 0.015 mg of EE + 0.120 mg of etonogestrel
Number of subjects: 556
Study 27908210 — intervention group
Group type: EXPERIMENTAL
Intervention: Progestin only subcutaneous contraceptive implant releasing etonogestrel
Number of subjects: 556
Study 27908210 — intervention group
Group type: COMPARATOR
Intervention: No hormonal contraceptive methods (controls)
Number of subjects: 556
Study 27908210 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound evaluation of dorsal clitoral artery
Number of subjects: 556
Study 25425394 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine 300U/ml (Gla‐300) administered at a dosage of 0.4U/kg once daily for six days
Number of subjects: 50
Study 25425394 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine 300U/ml (Gla‐300)
Number of subjects: 50
Study 23778372 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual chiropractic treatment
Number of subjects: 183
Study 23778372 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 183
Study 21060992 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-month course of circuit exercises plus a 3-hour lesson on coping with osteoporosis
Number of subjects: 89
Study 21060992 — intervention group
Group type: COMPARATOR
Intervention: Control group (CT)
Number of subjects: 89
Study 19261771 — intervention group
Group type: EXPERIMENTAL
Intervention: wP vaccine
Number of subjects: 234
Study 19261771 — intervention group
Group type: COMPARATOR
Intervention: wP(low) vaccine
Number of subjects: 234
Study 16954234 — intervention group
Group type: EXPERIMENTAL
Intervention: Primers amplifying the E2 coding region
Number of subjects: 939
Study 16954234 — intervention group
Group type: EXPERIMENTAL
Intervention: Primers amplifying the 5' nontranslated region and nonstructural protein-coding regions 3 and 5A
Number of subjects: 939
Study 16954234 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantitative GBV-C RNA method
Number of subjects: 939
Study 16954234 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjects with both GBV-C E2 antibody and viremia
Number of subjects: 939
Study 12612504 — intervention group
Group type: EXPERIMENTAL
Intervention: Pancreatic duct stent placement
Number of subjects: 0
Study 12612504 — intervention group
Group type: COMPARATOR
Intervention: No stent (control group)
Number of subjects: 0
Study 10692622 — intervention group
Group type: EXPERIMENTAL
Intervention: Focused attention
Number of subjects: 100
Study 10692622 — intervention group
Group type: COMPARATOR
Intervention: Avoidance
Number of subjects: 100
Study 10692622 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold pressor pain
Number of subjects: 100
Study 9354210 — intervention group
Group type: EXPERIMENTAL
Intervention: Pancrease MT4 (8000 unit lipase)
Number of subjects: 0
Study 9354210 — intervention group
Group type: EXPERIMENTAL
Intervention: Pancrease MT10 (20,000 units lipase)
Number of subjects: 0
Study 9354210 — intervention group
Group type: EXPERIMENTAL
Intervention: Pancrease MT16 (32,000 units lipase)
Number of subjects: 0
Study 9354210 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 1587874 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamma nail
Number of subjects: 186
Study 1587874 — intervention group
Group type: COMPARATOR
Intervention: Dynamic hip screw
Number of subjects: 186
Study 3984605 — intervention group
Group type: EXPERIMENTAL
Intervention: Piracetam treatment
Number of subjects: 60
Study 3984605 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 60
Study 31083659 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge of alcohol use among family physicians
Number of subjects: 1760
Study 31083659 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge of alcohol use among older professionals
Number of subjects: 1760
Study 31083659 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge of alcohol use among resident trainers
Number of subjects: 1760
Study 31083659 — intervention group
Group type: EXPERIMENTAL
Intervention: Advice for reducing alcohol use by nurses
Number of subjects: 1760
Study 31083659 — intervention group
Group type: EXPERIMENTAL
Intervention: Advice for reducing alcohol use by female professionals
Number of subjects: 1760
Study 31083659 — intervention group
Group type: EXPERIMENTAL
Intervention: Advice for reducing alcohol use by professionals aged 46 to 55
Number of subjects: 1760
Study 30290629 — intervention group
Group type: EXPERIMENTAL
Intervention: Gel cushion
Number of subjects: 75
Study 30290629 — intervention group
Group type: COMPARATOR
Intervention: Foam cushion
Number of subjects: 75
Study 26767313 — intervention group
Group type: EXPERIMENTAL
Intervention: ColoWrap (external abdominal compression device)
Number of subjects: 350
Study 26767313 — intervention group
Group type: COMPARATOR
Intervention: Sham device (control)
Number of subjects: 350
Study 26767313 — intervention group
Group type: EXPERIMENTAL
Intervention: ColoWrap (external abdominal compression device) in patients with BMI 30-40 kg/m(2)
Number of subjects: 350
Study 26767313 — intervention group
Group type: COMPARATOR
Intervention: Sham device (control) in patients with BMI 30-40 kg/m(2)
Number of subjects: 350
Study 23871316 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral and maxillofacial surgeon
Number of subjects: 746
Study 22002111 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraprostatic injection of epinephrine
Number of subjects: 23
Study 22002111 — intervention group
Group type: COMPARATOR
Intervention: Intraprostatic injection of saline solution (placebo)
Number of subjects: 23
Study 19967669 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-site phacotrabeculectomy
Number of subjects: 169
Study 19967669 — intervention group
Group type: COMPARATOR
Intervention: 2-site phacotrabeculectomy
Number of subjects: 169
Study 18261506 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine controlled‐release (12.5‐25 mg/d)
Number of subjects: 64
Study 18261506 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 11575418 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled isoflurane at end‐tidal concentration 1‐1.5% (group I, n=20)
Number of subjects: 38
Study 11575418 — intervention group
Group type: COMPARATOR
Intervention: Target‐controlled infusion (TCI) of propofol at target concentration 2‐5 microg ml(‐1) (group P, n=18)
Number of subjects: 38
Study 9932224 — intervention group
Group type: EXPERIMENTAL
Intervention: Home strip-analysis for all children
Number of subjects: 131
Study 9932224 — intervention group
Group type: EXPERIMENTAL
Intervention: Biological tests before clinical symptoms
Number of subjects: 131
Study 9932224 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening tests
Number of subjects: 131
Study 9932224 — intervention group
Group type: EXPERIMENTAL
Intervention: Recognition of increased risk
Number of subjects: 131
Study 9932224 — intervention group
Group type: EXPERIMENTAL
Intervention: Coping with disease recurrence
Number of subjects: 131
Study 8060926 — intervention group
Group type: EXPERIMENTAL
Intervention: Candoxatril 200 mg twice daily for 4 weeks
Number of subjects: 7
Study 8060926 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 2 weeks
Number of subjects: 7
Study 8060926 — intervention group
Group type: COMPARATOR
Intervention: Placebo washout for 3 days
Number of subjects: 7
Study 30982860 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-calorie diet (LCD) at 800 kcal/d
Number of subjects: 761
Study 30982860 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight maintenance dietary (WMD) intervention with different glycemic loads
Number of subjects: 761
Study 30982860 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline AMY1 CN
Number of subjects: 761
Study 30982860 — intervention group
Group type: EXPERIMENTAL
Intervention: Interaction analyses between AMY1 CN and nutrient intake
Number of subjects: 761
Study 29286032 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous braided suture (Group I)
Number of subjects: 302
Study 29286032 — intervention group
Group type: EXPERIMENTAL
Intervention: Bidirectional knotless barbed sutures (Group II)
Number of subjects: 302
Study 29286032 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 302
Study 26246480 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic oral steroid administration
Number of subjects: 360
Study 26246480 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic local steroid injection
Number of subjects: 360
Study 23831870 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of rifampin (600 mg)
Number of subjects: 12
Study 21685823 — intervention group
Group type: EXPERIMENTAL
Intervention: New ultrahigh-speed (UHS) 25-gauge system
Number of subjects: 120
Study 21685823 — intervention group
Group type: COMPARATOR
Intervention: Standard 25-gauge vitrectomy system
Number of subjects: 120
Study 19401528 — intervention group
Group type: EXPERIMENTAL
Intervention: 13‐cis RA/alpha tocopherol
Number of subjects: 75
Study 19401528 — intervention group
Group type: EXPERIMENTAL
Intervention: 13‐cis RA
Number of subjects: 75
Study 19401528 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 75
Study 19401528 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment (13‐cis RA and 13‐cis RA/alpha tocopherol)
Number of subjects: 75
Study 16775717 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitoring of internal thoracic impedance (ITI)
Number of subjects: 265
Study 15301627 — intervention group
Group type: EXPERIMENTAL
Intervention: Mortality Salience (MS)
Number of subjects: 0
Study 12577389 — intervention group
Group type: EXPERIMENTAL
Intervention: Infantile umbilical paste (IUP)
Number of subjects: 220
Study 12577389 — intervention group
Group type: COMPARATOR
Intervention: Compound Aspirin (APC)
Number of subjects: 220
Study 9359049 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose dipyridamole (up to 0.84 mg/kg over 10')
Number of subjects: 60
Study 9359049 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose dobutamine (up to 10 mcg/kg/min)
Number of subjects: 60
Study 9359049 — intervention group
Group type: COMPARATOR
Intervention: Control group (no pharmacological stress)
Number of subjects: 60
Study 8000787 — intervention group
Group type: EXPERIMENTAL
Intervention: Leptospirosis vaccine
Number of subjects: 0
Study 8000787 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimulation with Staphylococcus
Number of subjects: 0
Study 8000787 — intervention group
Group type: EXPERIMENTAL
Intervention: Spontaneous NBT test
Number of subjects: 0
Study 29624530 — intervention group
Group type: EXPERIMENTAL
Intervention: Point-of-care gastric ultrasound
Number of subjects: 40
Study 28535815 — intervention group
Group type: EXPERIMENTAL
Intervention: TAU + iABM
Number of subjects: 213
Study 28535815 — intervention group
Group type: COMPARATOR
Intervention: TAU + placebo condition
Number of subjects: 213
Study 28535815 — intervention group
Group type: COMPARATOR
Intervention: TAU-only
Number of subjects: 213
Study 25464237 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 125
Study 25464237 — intervention group
Group type: COMPARATOR
Intervention: Control (no RIPC)
Number of subjects: 125
Study 23240711 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol infusion (target breath alcohol concentration = 0.06 g/dl)
Number of subjects: 295
Study 23240711 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 295
Study 23240711 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol infusion
Number of subjects: 295
Study 22022215 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA cream
Number of subjects: 41
Study 22022215 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethyl chloride vapocoolant spray
Number of subjects: 41
Study 22022215 — intervention group
Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 41
Study 22022215 — intervention group
Group type: COMPARATOR
Intervention: Control (baseline pain assessment)
Number of subjects: 41
Study 19691847 — intervention group
Group type: EXPERIMENTAL
Intervention: Temporary fracture fixation with fixateur externe and defined secondary definitive treatment (DCO)
Number of subjects: 0
Study 19691847 — intervention group
Group type: COMPARATOR
Intervention: Primary reamed nailing (early total care)
Number of subjects: 0
Study 16968876 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported health-related quality of life (HRQOL)
Number of subjects: 391
Study 15614996 — intervention group
Group type: EXPERIMENTAL
Intervention: Phase locking value (PLV)
Number of subjects: 3
Study 15614996 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean spectral coherence
Number of subjects: 3
Study 15614996 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of phase synchronization measures with alpha power spectral density estimates
Number of subjects: 3
Study 15614996 — intervention group
Group type: COMPARATOR
Intervention: Power densities in alpha, beta1, beta2, and 8-30 Hz frequency bands
Number of subjects: 3
Study 11761499 — intervention group
Group type: EXPERIMENTAL
Intervention: Intercessory prayer group
Number of subjects: 799
Study 11761499 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 799
Study 11761499 — intervention group
Group type: EXPERIMENTAL
Intervention: Intercessory prayer group (high-risk)
Number of subjects: 799
Study 11761499 — intervention group
Group type: COMPARATOR
Intervention: Control group (high-risk)
Number of subjects: 799
Study 11761499 — intervention group
Group type: EXPERIMENTAL
Intervention: Intercessory prayer group (low-risk)
Number of subjects: 799
Study 11761499 — intervention group
Group type: COMPARATOR
Intervention: Control group (low-risk)
Number of subjects: 799
Study 9250464 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperfiltering IDDM patients
Number of subjects: 38
Study 9250464 — intervention group
Group type: EXPERIMENTAL
Intervention: IDDM patients
Number of subjects: 38
Study 8068482 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular recombinant IFN alpha‐2b
Number of subjects: 20
Study 8068482 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 3711577 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% tropicamide
Number of subjects: 0
Study 3711577 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5% phenylephrine
Number of subjects: 0
Study 3711577 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 1% tropicamide and 2.5% phenylephrine
Number of subjects: 0
Study 3711577 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31377992 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic Sleeve Gastrectomy (LSG)
Number of subjects: 16
Study 31377992 — intervention group
Group type: EXPERIMENTAL
Intervention: Biliopancreatic Diversion (BPD)
Number of subjects: 16
Study 29424121 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased donation frequency
Number of subjects: 30
Study 26856620 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic partial meniscectomy (APM)
Number of subjects: 146
Study 26856620 — intervention group
Group type: COMPARATOR
Intervention: Sham surgery
Number of subjects: 146
Study 26856620 — intervention group
Group type: EXPERIMENTAL
Intervention: APM (subgroup analysis)
Number of subjects: 146
Study 26856620 — intervention group
Group type: COMPARATOR
Intervention: Sham surgery (subgroup analysis)
Number of subjects: 146
Study 23847009 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Treatment (AT)
Number of subjects: 47
Study 22235841 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol 9 μg via Turbuhaler®
Number of subjects: 109
Study 22235841 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol 50 μg via Diskus®
Number of subjects: 109
Study 22235841 — intervention group
Group type: COMPARATOR
Intervention: Placebo via Turbuhaler® and Diskus®
Number of subjects: 109
Study 20178542 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter removal on 1st postoperative day
Number of subjects: 200
Study 20178542 — intervention group
Group type: COMPARATOR
Intervention: Catheter removal on 4th postoperative day
Number of subjects: 200